MedPath

A pilot study to characterize the effects of ageing on the innate immune response against influenza

Completed
Conditions
flu
Influenza
10047438
Registration Number
NL-OMON31944
Lead Sponsor
ederlands Vaccin Instituut
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
94
Inclusion Criteria

Subjects have to fulfil all the following criteria:
- 20-40 years or >= 65 years old
- vaccinated with most recent seasonal influenza vaccine
- having a signed informed consent form

Exclusion Criteria

The exclusion criteria are:
- immune deficiencies
- haematological disorders
- bleeding disorders
- usage of anticoagulants, corticosteroids, NSAIDs and/or statins
- diabetes mellitus

Study & Design

Study Type
Observational invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>To determine functional immune responses, after in vitro influenza infection of<br /><br>dendritic cells isolated from young adults and elderly people. The responses<br /><br>will be characterized based on; influenza-specific mRNA expressiom, maturation<br /><br>molecule expression, inhibitory molecule expression, cytokine production and T<br /><br>cell stimulating capacity.</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>To determine the variation of the assays for qualifying the innate immune<br /><br>response of DC isolated from young adults or elderly individuals.</p><br>
© Copyright 2025. All Rights Reserved by MedPath